BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Business

  Orchid Cellmark Reports Fourth Quarter and Full Year 2008 Financial Results

  March 16, 2009

   · 

  9 min read
• BioMidwest

  PuraMed BioScience Secures Initial Capital Funding

  March 16, 2009

   · 

  1 min read
• Oncothyreon Regains Compliance with NASDAQ Listing Requirements

  March 16, 2009

   · 

  2 min read
• Bio NC

  Metabolon: Metabolomics Technology Applied to Novel Toxicology Research

  March 16, 2009

   · 

  1 min read
• Drug Development

  Helix Biopharma Receives Approval to Initiate Phase II Pharmacokinetic Clinical Study of Topical Interferon Alpha-2b in Patients with Low-Grade Cervical Lesions

  March 16, 2009

   · 

  6 min read
• Biotech Bay

  Bayhill Therapeutics, Inc. Founder Lawrence Steinman, M.D. Recognized for Leadership in Multiple Sclerosis

  March 16, 2009

   · 

  1 min read
• Drug Development

  CytRx Corporation’s Arimoclomol Demonstrates Statistically Significant Neurorestorative Results in a Preclinical Embolic Stroke Trial

  March 16, 2009

   · 

  1 min read
• Business

  ERYtech Pharma is Authorized to Open Its Pharmaceutical Manufacturing Site

  March 16, 2009

   · 

  1 min read
• KARL STORZ GmbH & Co. KG North America Region Headquarters to New El Segundo Location

  March 16, 2009

   · 

  1 min read
• Drug Development

  Healthpoint Initiates Phase II, Dose-Finding Study to Evaluate Effectiveness of a Unique Cell Based Therapy in Venous Leg Ulcers

  March 16, 2009

   · 

  3 min read